Detalhe da pesquisa
1.
Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-ß1 in the metastatic process.
J Biol Inorg Chem
; 20(7): 1163-73, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26369538
2.
Dermoscopy of scalp tumours: a multi-centre study conducted by the international dermoscopy society.
J Eur Acad Dermatol Venereol
; 26(8): 953-63, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21790795
3.
Chitosan-coated alginate micro-particles delivery of active principles through conventional pelleted food - A study in Tilapia (Oreochromis niloticus).
Int J Biol Macromol
; 165(Pt A): 82-92, 2020 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32987084
4.
Influence of the binding of reduced NAMI-A to human serum albumin on the pharmacokinetics and biological activity.
Dalton Trans
; 44(4): 1905-13, 2015 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25489765
5.
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A.
Eur J Cancer
; 38(3): 427-35, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11818210
6.
Ruthenium-based compounds and tumour growth control (review).
Int J Oncol
; 17(2): 353-65, 2000 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-10891547
7.
Effects of L-(adamant-2-yl)glycyl-L-alanyl-d-isoglutamine on the antitumor action of cyclophosphamide, 5-fu, Cisplatin and dacarbazine on advanced carcinomas of the mouse.
Int J Oncol
; 5(2): 275-84, 1994 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21559586
8.
Stimulation of GALT and activation of mesenteric lymph node lymphocytes by a modified lysozyme in CBA mice with MCa mammary carcinoma.
J Exp Ther Oncol
; 1(6): 342-9, 1996 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-9414423
9.
Drug control of solid tumour metastases: a critical view.
Anticancer Res
; 19(2A): 1117-24, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10368662
10.
Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas.
Anticancer Res
; 15(5B): 1883-8, 1995.
Artigo
em Inglês
| MEDLINE | ID: mdl-8572573
11.
Treatment of metastases of solid mouse tumours by NAMI-A: comparison with cisplatin, cyclophosphamide and dacarbazine.
Anticancer Res
; 19(2A): 969-72, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10368640
12.
Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A.
Anticancer Res
; 20(5A): 2939-44, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-11062704
13.
Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma.
Anticancer Res
; 16(5A): 2559-64, 1996.
Artigo
em Inglês
| MEDLINE | ID: mdl-8917351
14.
Cytofluorimetric analysis of gut-intraepithelial and mesenteric lymph node lymphocytes of tumour bearing mice fed with egg-white lysozyme.
Anticancer Res
; 16(1): 145-9, 1996.
Artigo
em Inglês
| MEDLINE | ID: mdl-8615600
15.
Tumour cell uptake G2-M accumulation and cytotoxicity of NAMI-A on TS/A adenocarcinoma cells.
Anticancer Res
; 21(3B): 1893-8, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11497274
16.
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[[trans-RuCl4(Me2SO)]2(mu-L)] (L = ditopic, non-chelating aromatic N-ligand). A preliminary investigation.
J Inorg Biochem
; 79(1-4): 173-7, 2000 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10830863
17.
Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry.
Chem Biol Interact
; 113(1): 51-64, 1998 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9630847
18.
Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition.
Chem Biol Interact
; 95(1-2): 109-26, 1995 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-7697744
19.
Synthetic thymic fraction 5: effects of high dose administration on circulating lymphocytes in patients.
Cancer Biother Radiopharm
; 11(2): 105-11, 1996 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10851526
20.
Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates.
J Inorg Biochem
; 106(1): 90-9, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22112845